Ultimovacs ASA Reports Fourth Quarter 2024 Financial Results and Provides General Business Update
Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company…
Ultimovacs ASA: Regarding the extraordinary general meeting on 9 January 2025
Oslo, 5 January 2025: Reference is made to the stock exchange notice…